Mannkind (MNKD) Net Margin Growth (5y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,565.00 |
| Dec 31, 2025 | 12,454.00 |
| Sep 30, 2025 | 8,303.00 |
| Jun 30, 2025 | 512,687.00 |
| Mar 31, 2025 | 7,421.00 |
| Dec 31, 2024 | 9,347.00 |
| Sep 30, 2024 | 149,791.00 |
| Jun 30, 2024 | 619,072.00 |
| Mar 31, 2024 | 10,134.00 |
| Dec 31, 2023 | 4,746.00 |
| Sep 30, 2023 | 54,777.00 |
| Jun 30, 2023 | 57,162.00 |
| Mar 31, 2023 | 85,280.00 |
| Dec 31, 2022 | -183,553.00 |
| Sep 30, 2022 | 156,573.00 |
| Jun 30, 2022 | -804,054.00 |
| Mar 31, 2022 | 32,571.00 |
| Dec 31, 2021 | -65,935.00 |
| Sep 30, 2021 | -9,786.00 |
| Sep 30, 2017 | 12.08 Mn |